Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ramipril 2.5 mg tablet
Therapeutic Category
Hypertension/ Blood Pressure, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹58.35/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ramipil 2.5 Tablet is an antihypertensive medication that belongs to the class of angiotensin-converting enzyme (ACE) inhibitors. It works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby relaxing blood vessels, lowering vascular resistance, and reducing blood pressure. Ramipril also decreases aldosterone secretion, leading to reduced sodium and water retention, which further aids in controlling blood pressure and reducing cardiac workload. The 2.5 mg strength is typically used as a starting dose in patients with mild to moderate hypertension, heart failure, or as an initial dose following myocardial infarction in high-risk patients. Ramipril not only controls blood pressure but also offers cardioprotective and renoprotective benefits, making it valuable in patients with diabetes, chronic kidney disease, or those at high risk of cardiovascular events.
Common side effects include dizziness, headache, fatigue, and dry cough (a class effect of ACE inhibitors). Some patients may experience low blood pressure (hypotension), nausea, or gastrointestinal discomfort. Rare but serious adverse effects include hyperkalemia, angioedema (swelling of the face, lips, or throat), and impaired kidney function. Patients should report any signs of swelling or difficulty breathing immediately.
Ramipril 2.5 mg Tablet is indicated for the treatment of essential hypertension, congestive heart failure, and as part of therapy to reduce the risk of myocardial infarction, stroke, and cardiovascular death in high-risk patients. It is also used for slowing the progression of diabetic and non-diabetic nephropathy.
Ramipril 2.5 mg should only be used under medical supervision. It is contraindicated in pregnancy, especially in the second and third trimesters, due to the risk of fetal harm. Caution is advised in patients with severe kidney impairment, bilateral renal artery stenosis, or a history of angioedema. Potassium supplements or potassium-sparing diuretics should be avoided unless specifically prescribed, as ACE inhibitors can increase serum potassium levels. Alcohol consumption should be limited as it can enhance the blood pressure-lowering effect. The medication should not be discontinued abruptly without consulting a physician. Regular monitoring of blood pressure, kidney function, and electrolytes is recommended during long-term use.
Store Ramipril 2.5 mg Tablet in a cool, dry place below 30°C. Protect it from moisture and direct sunlight. Keep out of reach of children and pets. Do not use the tablet beyond the expiry date mentioned on the strip or packaging.
Composition : Ramipril (10mg) tablet
Composition : Ramipril 1.25 mg tablet
Composition : Ramipril 2.5 mg + amlodipine 5 mg tablet
Composition : Ramipril 2.5 mg tablet
Composition : Ramipril 5 mg + Hydrochlorothiazide 12.5 mg tablet
Composition : Ramipril 5 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ramipril 2.5 mg Tablet is an ACE inhibitor antihypertensive medication used for the management of hypertension (high blood pressure), heart failure, and reduction of cardiovascular risk in high-risk patients. It works by relaxing blood vessels, improving blood flow, and reducing the workload on the heart. This makes it an important product in the cardiology and cardiovascular care segment, with strong demand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from cardiologists, physicians, and general practitioners. As cardiovascular diseases and hypertension require long-term management, Ramipril 2.5 mg provides steady prescriptions, repeat orders, and stable market growth, making it a strong addition to the cardiac portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiac and antihypertensive segment with monopoly rights, quality manufacturing standards, attractive promotional support, and reliable supply chain assistance for distributors and franchise partners.
Wholesalers and distributors benefit from strong prescription demand, long-term patient adherence, increasing prevalence of cardiovascular diseases, and continuous institutional requirements, making this product a profitable and sustainable addition to their pharmaceutical portfolio when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and antihypertensive formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiac segment.